# OPANA ER
> **NDA201655** · New Drug Application · Sponsor: ENDO PHARMS · Approved 2011-12-09
## Drug
- **FDA Application Number:** NDA201655
- **Application type:** New Drug Application
- **Brand name:** OPANA ER
- **Generic name:** Oxymorphone Hydrochloride
- **Active ingredients:** OXYMORPHONE HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ENDO PHARMS
- **First approval:** 2011-12-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201655)
---
*MORVS · CC0 1.0*